SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-20-002260
Filing Date
2020-04-01
Accepted
2020-04-01 16:18:49
Documents
2
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 12449
2 EXHIBIT 24.1 exh_241.htm EX-24.1 8767
  Complete submission text file 0001171843-20-002260.txt   22555
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address
D'Alvise Janelle (Reporting) CIK: 0001807412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 20765630